Synthetic cannabinoid use in a nationally representative sample of US high school seniors
- PMID: 25736618
- PMCID: PMC4361370
- DOI: 10.1016/j.drugalcdep.2015.01.044
Synthetic cannabinoid use in a nationally representative sample of US high school seniors
Abstract
Background: Synthetic cannabinoids are marketed as "legal highs" and have similar effects to cannabis (marijuana). Although prevalence of synthetic cannabinoid use is now declining in the US, use has been associated with tens of thousands of poisonings and hospitalizations, particularly among teens. It is important to examine which teens are at highest risk for use of these new, potentially deleterious drugs as they are understudied and continue to emerge.
Methods: Data were analyzed from a nationally representative sample of high school seniors in the Monitoring the Future study (2011-2013; Weighted N = 11,863; modal age: 18). Bivariable and multivariable models were used to delineate correlates of recent (12-month) synthetic cannabinoid use.
Results: Ten percent reported any recent use and 3% reported more frequent use (used ≥ 6 times). Females were at low odds for use and going out 4-7 evenings per week for fun consistently increased odds of use. Black and religious students were at low odds of use until controlling for other drug use, and higher income increased odds of use until controlling for other drug use. Lifetime use of alcohol, cigarettes and other illicit drugs all robustly increased odds of use, but frequency of lifetime marijuana use was the strongest correlate with more frequent use further increasing odds of synthetic cannabinoid use. Only 0.5% of non-marijuana users reported use of synthetic cannabinoids.
Conclusions: This is among the first national studies to delineate correlates of synthetic cannabinoid use. Results can inform national and local efforts to prevent use and adverse consequences resulting from use.
Keywords: Adolescents; Marijuana; Sociodemographics; Synthetic cannabinoids.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Conflict of interest statement
No conflict declared.
Similar articles
-
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States.Am J Drug Alcohol Abuse. 2015 May;41(3):197-205. doi: 10.3109/00952990.2015.1011745. Epub 2015 Apr 10. Am J Drug Alcohol Abuse. 2015. PMID: 25860964 Free PMC article.
-
Synthetic Cannabinoid Use Among High School Seniors.Pediatrics. 2017 Oct;140(4):e20171330. doi: 10.1542/peds.2017-1330. Epub 2017 Sep 11. Pediatrics. 2017. PMID: 28893851 Free PMC article.
-
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015.Drug Alcohol Depend. 2016 Sep 1;166:159-67. doi: 10.1016/j.drugalcdep.2016.07.018. Epub 2016 Jul 28. Drug Alcohol Depend. 2016. PMID: 27491817 Free PMC article.
-
International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.Brain Res Bull. 2016 Sep;126(Pt 1):8-28. doi: 10.1016/j.brainresbull.2016.04.013. Epub 2016 Apr 21. Brain Res Bull. 2016. PMID: 27108542 Review.
-
The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.J Clin Pharmacol. 2017 Mar;57(3):297-304. doi: 10.1002/jcph.827. Epub 2016 Oct 13. J Clin Pharmacol. 2017. PMID: 27610597 Review.
Cited by
-
Health Risk Behaviors With Synthetic Cannabinoids Versus Marijuana.Pediatrics. 2017 Apr;139(4):e20162675. doi: 10.1542/peds.2016-2675. Epub 2017 Mar 13. Pediatrics. 2017. PMID: 28289138 Free PMC article.
-
The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol.Syst Rev. 2016 Nov 21;5(1):195. doi: 10.1186/s13643-016-0375-5. Syst Rev. 2016. PMID: 27871332 Free PMC article.
-
Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).Clin Toxicol (Phila). 2019 Jan;57(1):10-18. doi: 10.1080/15563650.2018.1485927. Epub 2018 Jul 10. Clin Toxicol (Phila). 2019. PMID: 29989463 Free PMC article.
-
Exacerbated cardiac dysfunction from combined alcohol binge and synthetic cannabinoid use.Biomed Pharmacother. 2025 Jun;187:118053. doi: 10.1016/j.biopha.2025.118053. Epub 2025 Apr 26. Biomed Pharmacother. 2025. PMID: 40288176
-
Substance use among adolescents and young adults with chronic kidney disease or kidney failure.Pediatr Nephrol. 2021 Nov;36(11):3585-3593. doi: 10.1007/s00467-021-05001-2. Epub 2021 Mar 9. Pediatr Nephrol. 2021. PMID: 33686466 Review.
References
-
- American Association of Poison Control Centers. [accessed 03.01.15];Synthetic Cannabinoid Data. 2014 http://www.aapcc.org/alerts/synthetic-marijuana.
-
- Barratt MJ, Cakic V, Lenton S. Patterns of synthetic cannabinoid use in Australia. Drug Alcohol Rev. 2013;32:141–146. - PubMed
-
- Bernson-Leung ME, Leung LY, Kumar S. Synthetic cannabis and acute ischemic stroke. J Stroke Cerebrovasc. 2013;23:1239–1241. - PubMed
-
- Bruno R, Matthews AJ, Dunn M, Alati R, McIlwraith F, Hickey S, Burns L, Sindicich N. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend. 2012;124:19–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources